All articles tagged with #regulatory oversight
An FDA-organized media call featured a senior FDA official publicly attacking UniQure’s Huntington’s disease gene therapy, calling its data distorted and the therapy failed, a move seen as injecting politics into rare-disease regulation and potentially complicating oversight ahead of elections, with echoes of recent vaccine-review controversies and congressional pressure on the agency.
EU independent advisers say Europe is unprepared for worsening climate change and must ramp up adaptation investments to protect people and infrastructure from floods, wildfires and heatwaves, noting 45 billion euros in annual damages. They call for cross-border planning for higher warming by 2100, stronger early-warning systems, expanded insurance (potential EU-level reinsurance), and a new EU resilience strategy due later this year.
The U.S. Senate Banking Committee postponed a discussion of a draft cryptocurrency regulation bill hours after Coinbase CEO Brian Armstrong opposed it, arguing the plan would define tokens as securities or commodities and could curb tokenized equities and stablecoin rewards; with Coinbase’s backing in doubt, the bill’s fate remains uncertain.
A US Coast Guard investigation found that the 2023 Titan submersible disaster was preventable due to OceanGate's flawed safety practices, inadequate design, and regulatory evasion, highlighting the need for stronger oversight of novel vessel operations.
A research team alleges that Pfizer concealed two deaths during its COVID-19 vaccine clinical trials, potentially indicating dangerous side effects. The deaths, one in Kansas and another in Georgia, were not reported in a timely manner, raising concerns about the trial's integrity and the vaccine's safety. The researchers argue that these omissions could have influenced the vaccine's emergency use authorization and highlight potential cardiovascular risks associated with the vaccine. The findings suggest Pfizer may have been aware of these risks before the vaccine's approval.
A study published in The American Journal of Clinical Nutrition found that many prenatal vitamins contain toxic heavy metals like cadmium, arsenic, and lead, which may increase the risk of autism and other health issues in children. Researchers tested 47 prenatal vitamins and discovered discrepancies between label claims and actual contents, highlighting the need for stronger regulatory oversight. Despite these concerns, prenatal vitamins remain important, and women are advised to consult healthcare professionals to choose safe options.
A new study from the University of Colorado Anschutz Medical Campus reveals that some prenatal vitamins contain concerning levels of toxic heavy metals like arsenic, lead, and cadmium, while others lack essential nutrients such as choline and iodine. The study tested 47 prenatal vitamins and found discrepancies between label claims and actual contents, with some products exceeding safety limits for heavy metals. Despite these findings, researchers still recommend taking prenatal vitamins during pregnancy but urge stronger regulatory oversight and careful selection of supplements.
Treasury Secretary Janet Yellen will warn about the significant risks of using AI in finance, despite its benefits, in a speech at an AI conference. She will highlight AI's potential to improve efficiency and access to financial services but also point out vulnerabilities such as model complexity, data biases, and concentration risks. Yellen emphasizes the need for robust risk management frameworks and scenario analysis to address these challenges.
Microsoft is making a major push in the AI space after hiring co-founders from Inflection AI, absorbing much of its staff into a new division to avoid regulatory oversight. The move reflects Microsoft's increasing focus on AI, with developments including a new GPT model from OpenAI and AI-related news in Surface and Windows products.
Regional banks are facing a new crisis as shaky commercial loans threaten their stability, contrasting with the previous crisis caused by risky investments. This time, banks like NYCB are struggling due to misjudging their own borrowers and making loans to businesses that weren't creditworthy or charging insufficient interest to compensate for the risk. The situation raises concerns about regulatory oversight, as NYCB was previously deemed strong enough to acquire another failed bank, highlighting potential governance challenges.
The Consumer Financial Protection Bureau (CFPB) has proposed a new rule to supervise larger nonbank companies, including Big Tech firms, that offer digital wallets and payment apps. The rule aims to ensure that these companies, handling more than 5 million transactions per year, adhere to the same rules as banks and credit unions. The CFPB's oversight would help protect consumers by ensuring compliance with consumer protection laws and promoting fair competition in the marketplace. This proposed rule is part of the CFPB's efforts to monitor the entry of Big Tech into consumer financial markets and address potential risks.
Silvergate Bank, a community lender turned crypto bank, was able to take risky actions without raising alarm from its Federal Reserve examiners, leading to its downfall, according to a report from the Federal Reserve's Office of Inspector General (OIG). The OIG found that the bank's change in course should have required a different type of registration, but government supervisors failed to demand it. The report also highlighted issues with the bank's senior management and its ineffective corporate governance and risk management capabilities. The bank voluntarily liquidated, avoiding government intervention, but the OIG made recommendations for improved regulatory oversight in similar situations.
Cryptocurrency lobbyists are facing challenges in Washington as they struggle to gain access to key officials and congressional offices. The downfall of FTX, including the arrest of its founder Sam Bankman-Fried on fraud charges, has tarnished the industry's reputation and led to increased skepticism from lawmakers. Lobbying efforts by surviving crypto companies continue, but they are having to shift strategies and distance themselves from FTX. The upcoming trial of Bankman-Fried has prompted the industry to change the subject and focus on other issues. Despite the challenges, the crypto industry is still pouring millions of dollars into lobbying and remains determined to shape regulatory oversight in its favor.
Toxic cough syrup made and sold in India may have been the start of a recent global wave of contamination, with at least 141 children dying in Gambia, Uzbekistan, and Cameroon. Investigations have revealed that some of the drugmakers implicated in these cases did not test their products for known toxins or could not prove that they did so, in violation of Indian law. Despite intense lobbying, no one has been found guilty in a court of law for the cough syrup deaths. The lack of oversight and regulatory loopholes in India's pharmaceutical industry have allowed for the production and sale of toxic medicines, leaving bereaved parents still waiting for justice.
Norfolk Southern, a major freight railroad, has been criticized by federal regulators for its safety culture following a train derailment, fire, and toxic chemical spill near an Ohio town. The Federal Railroad Administration's report highlighted poor communication and mistrust between employees and managers, questioning the adequacy of the company's training. The agency emphasized the need for a safety-focused culture and operations in the industry. Norfolk Southern is collaborating with workers to address the findings and has committed to making improvements. The agency plans to conduct similar safety culture reviews at other major freight railroads. Proposed legislation to improve safety in the industry has stalled in Congress.